AXSM - Axsome Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AXSM is currently covered by 14 analysts with an average price target of $157.34. This is a potential upside of $47.42 (43.14%) from yesterday's end of day stock price of $109.92.

Axsome Therapeutics's activity chart (see below) currently has 164 price targets and 195 ratings on display. The stock rating distribution of AXSM is 95.05% BUY and 4.95% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.04% with an average time for these price targets to be met of 320.45 days.

Highest price target for AXSM is $216, Lowest price target is $105, average price target is $158.42.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 03-Apr-2025. First documented stock forecast 19-May-2017.

Currently out of the existing stock ratings of AXSM, 96 are a BUY (95.05%), 5 are a HOLD (4.95%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$200

$93.73 (88.20%)

$200

26 days ago
(03-Apr-2025)

6/37 (16.22%)

$92.11 (85.37%)

108

Buy

$153

$46.73 (43.97%)

$153

28 days ago
(01-Apr-2025)

8/12 (66.67%)

$41.33 (37.01%)

98

Buy

$216

$109.73 (103.26%)

$212

1 months 2 days ago
(27-Mar-2025)

18/21 (85.71%)

$94.23 (77.38%)

229

Buy

$160

$53.73 (50.56%)

$116

1 months 26 days ago
(03-Mar-2025)

2/3 (66.67%)

$32.46 (25.45%)

181

Buy

$190

$83.73 (78.79%)

$115

2 months 2 days ago
(27-Feb-2025)

19/20 (95%)

$63.59 (50.30%)

356

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AXSM (Axsome Therapeutics) average time for price targets to be met?

On average it took 320.45 days on average for the stock forecasts to be realized with a an average price target met ratio 75.04

Which analyst has the current highest performing score on AXSM (Axsome Therapeutics) with a proven track record?

JOSEPH THOME

Which analyst has the most public recommendations on AXSM (Axsome Therapeutics)?

Joseph Thome works at TD COWEN and has 7 price targets and 3 ratings on AXSM

Which analyst is the currently most bullish on AXSM (Axsome Therapeutics)?

Graig Suvannavejh with highest potential upside - $109.73

Which analyst is the currently most reserved on AXSM (Axsome Therapeutics)?

Marc Goodman with lowest potential downside - -$21.27

Axsome Therapeutics in the News

ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial Inc. (NASDAQ: VIRT), as Securities Fraud Class Actions Survive Motions to Dismiss

PHILADELPHIA, April 08, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) as an underlying securities fraud class action has survived a motion to dismiss the complaint. The investigation concerns whether certain officers...

Axsome Therapeutics to Report First Quarter 2025 Financial Results on May 5

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will report its financial results for the first quarter of 2025 on Monday, May 5, 2025, before the opening of the U.S. financial...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?